Abemaciclib 150 mg

What is Abemaciclib 150 mg?

Abemaciclib 150 mg is a prescription medication containing the active ingredient Abemaciclib, which belongs to a class of drugs known as cyclin-dependent kinase (CDK) inhibitors. It is specifically designed to help manage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. The medication works by targeting cancer cell growth at the molecular level, thereby helping to slow the progression of the disease.

Manufactured by the reputable pharmaceutical company Eli Lilly and Company India, Abemaciclib 150 mg is recognized for its effectiveness in combination therapy settings. Healthcare professionals in Canada commonly prescribe this medication as part of a broader treatment plan tailored for patients diagnosed with advanced breast cancer. Its formulation as a 150 mg tablet allows for precise dosing based on individual patient needs.

Uses of Abemaciclib 150 mg

• Treatment of metastatic breast cancer that is HR+ and HER2-
• Used in combination with hormone therapies like letrozole 2.5 mg or fulvestrant
• Management of advanced or recurrent breast cancer cases
• Helps delay disease progression in eligible patients (other strengths: abemaciclib 100 mg and abemaciclib 200 mg)

How Abemaciclib 150 mg Works

Abemaciclib 150 mg functions by inhibiting CDK4 and CDK6 enzymes, which play a pivotal role in the cell cycle regulation. These enzymes are essential for cancer cells to proliferate. By blocking their activity, Abemaciclib prevents affected cancer cells from advancing from the G1 phase to the S phase of the cell cycle. This interruption in progression ultimately reduces cancer cell growth and division.

Because Abemaciclib specifically targets the molecular pathways crucial for tumor growth, it offers a precise and targeted approach. This specificity is important as it helps in minimizing damage to normal cells while focusing on cancerous cells, improving treatment tolerance and outcomes.

Benefits of Abemaciclib 150 mg

• Effectively slows progression of metastatic breast cancer
• Can be combined with hormone therapies for enhanced efficacy
• Oral administration allows convenient dosing
• Helps improve progression-free survival rates
• Targets cancer cells specifically, reducing impact on healthy cells
• Supported by clinical trials and regulatory approvals

Dosage and Administration

The usual recommended dosage of Abemaciclib 150 mg is two tablets taken orally twice daily, approximately 12 hours apart. The tablets should be swallowed whole with water and can be taken with or without food. It is important to follow your healthcare provider's specific instructions regarding dosing adjustments based on tolerance, side effects, and concurrent medications.

Your prescribing physician will monitor your response to treatment and may adjust the dose accordingly. Regular clinical evaluations and blood tests are necessary to ensure safety and therapeutic effectiveness.

Who Should Use Abemaciclib 150 mg?

Abemaciclib 150 mg is intended for:

• Adults diagnosed with HR+, HER2- metastatic breast cancer
• Patients suitable for combination therapy with hormone treatments
• Individuals who have not responded adequately to previous hormonal therapies
• Those under close medical supervision for cancer treatment planning

Who Should Avoid Abemaciclib 150 mg?

Abemaciclib 150 mg should be avoided by:

• Patients with known hypersensitivity to Abemaciclib or any tablet component
• Individuals with severe liver impairment
• Pregnant or breastfeeding women unless advised by a healthcare provider
• Patients with severe bone marrow suppression or low blood cell counts

Side Effects

• Diarrhea
• Nausea
• Fatigue
• Neutropenia (low white blood cell counts)
• Anemia (low red blood cell counts)
• Hair thinning or loss
• Abdominal pain
• Decreased appetite
• Infections
• Elevated liver enzymes
• Shortness of breath

Safety Advice

• Inform your doctor about all existing medical conditions
• Report any signs of infection or unusual bleeding immediately
• Do not discontinue medication without consulting your healthcare provider
• Avoid grapefruit or grapefruit juice during treatment
• Regular blood tests are necessary to monitor blood cell counts and liver function
• Keep hydrated to manage diarrhea effectively
• Use reliable contraception to avoid pregnancy during treatment
• Store medication out of reach of children

Drug Interactions

• Strong CYP3A inhibitors (may increase drug levels)
• Strong CYP3A inducers (may reduce drug effectiveness)
• Other medications causing bone marrow suppression, including some cancer therapies such as palbociclib
• Hormone therapies such as letrozole or fulvestrant used concurrently

Storage Instructions

Store Abemaciclib 150 mg tablets in a cool, dry place at room temperature (20-25°C). Keep the medication in its original packaging to protect it from moisture and light. Ensure the storage area is out of reach of children and pets. Do not use the medication past the expiration date indicated on the package.

Where to buy Abemaciclib 150 mg in Canada?

Abemaciclib 150 mg is available at licensed pharmacies across Canada with a valid prescription from an authorized healthcare professional. It can also be obtained via online Canadian pharmacy platforms that comply with regulatory standards. Always purchase from reputable sources to ensure product authenticity and safety.

Frequently Asked Questions (FAQ)

Is Abemaciclib 150 mg available in Canada?

Yes, Abemaciclib 150 mg is available in Canada through licensed pharmacies and requires a prescription from a qualified healthcare provider.

What is the price of Abemaciclib 150 mg in Canada?

The price of Abemaciclib 150 mg varies by pharmacy and insurance coverage. It is advisable to check with local pharmacies or healthcare providers for precise pricing and coverage details.

What happens if I miss a dose?

If you miss a dose of Abemaciclib 150 mg, take it as soon as you remember on the same day. Do not double the dose the next time; continue with your regular dosing schedule. Consult your doctor if you are unsure.

Where can I find Abemaciclib 150 mg for sale?

You can find Abemaciclib 150 mg for sale at certified pharmacies and authorized online platforms in Canada. Always ensure the source is legitimate to avoid counterfeit products.

Can I take Abemaciclib 150 mg with other medications?

Abemaciclib may interact with certain drugs, particularly CYP3A inhibitors or inducers. Always inform your doctor about all medications you are taking to avoid adverse interactions.

How long does it take for Abemaciclib 150 mg to work?

The therapeutic effects may be observed after several weeks of consistent treatment; however, your doctor will monitor your progress regularly to adjust treatment as needed.

Are there any dietary restrictions while taking Abemaciclib 150 mg?

It is recommended to avoid grapefruit and grapefruit juice as they can affect the metabolism of Abemaciclib. Maintain a balanced diet and stay hydrated during treatment.

Conclusion

Abemaciclib 150 mg is a well-established targeted therapy option designed to manage HR+, HER2- metastatic breast cancer effectively. Manufactured by Eli Lilly and Company India, this medication offers patients in Canada an advanced treatment choice supported by clinical evidence and designed to improve disease control with manageable safety profiles. When used under strict medical supervision, Abemaciclib 150 mg plays a crucial role in modern oncology care, helping patients achieve better treatment outcomes. Read the FDA announcement on abemaciclib with endocrine therapy for current approved uses.